{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:07:42Z","timestamp":1788984462509,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,8]]},"DOI":"10.7759\/cureus.98684","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T09:55:16Z","timestamp":1765187716000},"source":"Crossref","is-referenced-by-count":1,"title":["Added Value of Nucleic Acid Testing in Blood Banks: A 15-Year Retrospective Study from India"],"prefix":"10.7759","author":[{"given":"Sangeeta","family":"Pathak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surjit","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamojit","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish","family":"Kaushik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchi","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s12288-022-01598-y","article-title":"Blood donation screening of transfusion-transmissible viral infection using two different nucleic acid testing (NAT) platforms: a single tertiary care oncology centre experience","volume":"39","author":"Pathak A","year":"2023","unstructured":"Pathak A, Panda D, Sharma M, Tejwani N, Mehta A. Blood donation screening of transfusion-transmissible viral infection using two different nucleic acid testing (NAT) platforms: a single tertiary care oncology centre experience. Indian J Hematol Blood Transfus. 2023, 39:456-63. 10.1007\/s12288-022-01598-y","journal-title":"Indian J Hematol Blood Transfus"},{"key":"ref2","unstructured":"Guidelines for blood donor selection & blood donor referral. (2017). Accessed. October 29, 2025: https:\/\/www.naco.gov.in\/sites\/default\/files\/Letter%20reg.%20%20guidelines%20for%20blood%20donor%20selection%20%26%20r...."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4066\/AMJ.2011.641","article-title":"Profile of blood donors and reasons for deferral in coastal South India","volume":"4","author":"Unnikrishnan B","year":"2011","unstructured":"Unnikrishnan B, Rao P, Kumar N, et al.. Profile of blood donors and reasons for deferral in coastal South India. Australas Med J. 2011, 4:379-85. 10.4066\/AMJ.2011.641","journal-title":"Australas Med J"},{"key":"ref4","article-title":"Comparison of seropositivity of HIV, HBV, HCV and syphilis in replacement and voluntary blood donors in western India","volume":"44","author":"Garg S","year":"2001","unstructured":"Garg S, Mathur DR, Garg DK. Comparison of seropositivity of HIV, HBV, HCV and syphilis in replacement and voluntary blood donors in western India. Indian J Pathol Microbiol. 2001, 44:409-12.","journal-title":"Indian J Pathol Microbiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/trf.14457","article-title":"Sensitivity and specificity of a new automated system for the detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus nucleic acid in blood and plasma donations","volume":"58","author":"Galel SA","year":"2018","unstructured":"Galel SA, Simon TL, Williamson PC, et al.. Sensitivity and specificity of a new automated system for the detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus nucleic acid in blood and plasma donations. Transfusion. 2018, 58:649-59. 10.1111\/trf.14457","journal-title":"Transfusion"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_1340_17","article-title":"Nucleic acid amplification test: bridging the gap in blood safety & re-evaluation of blood screening for cryptic transfusion-transmitted infection among Indian donors","volume":"149","author":"Datta S","year":"2019","unstructured":"Datta S, Khillan K, Ranjan V, Wattal C. Nucleic acid amplification test: bridging the gap in blood safety & re-evaluation of blood screening for cryptic transfusion-transmitted infection among Indian donors. Indian J Med Res. 2019, 149:389-95. 10.4103\/ijmr.IJMR_1340_17","journal-title":"Indian J Med Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1366431","article-title":"Establishing a screening strategy for non-discriminatory reactive blood donors by constructing a predictive model of hepatitis B virus infection status from a single blood center in China","volume":"12","author":"Wu D","year":"2024","unstructured":"Wu D, Hu Y, Wang M, Wu Y, Dong J, Liu J, Hu W. Establishing a screening strategy for non-discriminatory reactive blood donors by constructing a predictive model of hepatitis B virus infection status from a single blood center in China. Front Public Health. 2024, 12:1366431. 10.3389\/fpubh.2024.1366431","journal-title":"Front Public Health"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1159\/000457965","article-title":"Three-year experience in Nat screening of blood donors for transfusion transmitted viruses in Croatia","volume":"44","author":"Safic Stanic H","year":"2017","unstructured":"Safic Stanic H, Babic I, Maslovic M, et al.. Three-year experience in Nat screening of blood donors for transfusion transmitted viruses in Croatia. Transfus Med Hemother. 2017, 44:415-20. 10.1159\/000457965","journal-title":"Transfus Med Hemother"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_424_23","article-title":"NAT yield in blood donors: an observational study","volume":"12","author":"Sharma A","year":"2023","unstructured":"Sharma A, Bundas S, Parashar R. NAT yield in blood donors: an observational study. J Family Med Prim Care. 2023, 12:2763-7. 10.4103\/jfmpc.jfmpc_424_23","journal-title":"J Family Med Prim Care"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/IJPM.IJPM_361_16","article-title":"Nucleic acid amplification testing in Indian blood banks: a review with perspectives","volume":"60","author":"Ghosh K","year":"2017","unstructured":"Ghosh K, Mishra K. Nucleic acid amplification testing in Indian blood banks: a review with perspectives. Indian J Pathol Microbiol. 2017, 60:313-8. 10.4103\/IJPM.IJPM_361_16","journal-title":"Indian J Pathol Microbiol"},{"key":"ref11","unstructured":"cobas\u00ae TaqScreen MPX Test, version 2.0. (2025). Accessed. October 29, 2025: https:\/\/www.fda.gov\/media\/90248\/download."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7184.203442","article-title":"Seroprevalence of transfusion-transmissible infections among replacement and voluntary blood donors in a tertiary care hospital","volume":"38","author":"Arora D","year":"2017","unstructured":"Arora D, Garg K, Rawat DS. Seroprevalence of transfusion-transmissible infections among replacement and voluntary blood donors in a tertiary care hospital. Indian J Sex Transm Dis AIDS. 2017, 38:101-2. 10.4103\/0253-7184.203442","journal-title":"Indian J Sex Transm Dis AIDS"},{"key":"ref13","article-title":"Blood Product Safety","author":"Harris JC","year":"2025","unstructured":"Harris JC, Crookston KP. Blood Product Safety. StatPearls [Internet], StatPearls Publishing, Treasure Island, FL; 2025."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4103\/0973-6247.175423","article-title":"Nucleic acid testing: is it the only answer for safe blood in India?","volume":"10","author":"Naidu NK","year":"2016","unstructured":"Naidu NK, Bharucha ZS, Sonawane V, Ahmed I. Nucleic acid testing: is it the only answer for safe blood in India?. Asian J Transfus Sci. 2016, 10:79-83. 10.4103\/0973-6247.175423","journal-title":"Asian J Transfus Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/0973-6247.126684","article-title":"Sensitivity of individual and mini-pool nucleic acid testing assessed by dilution of hepatitis B nucleic acid testing yield samples","volume":"8","author":"Chatterjee K","year":"2014","unstructured":"Chatterjee K, Agarwal N, Coshic P, Borgohain M, Chakroborty S. Sensitivity of individual and mini-pool nucleic acid testing assessed by dilution of hepatitis B nucleic acid testing yield samples. Asian J Transfus Sci. 2014, 8:26-8. 10.4103\/0973-6247.126684","journal-title":"Asian J Transfus Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2016.11.003","article-title":"NAT positivity in seronegative voluntary blood donors from western India","volume":"56","author":"Mishra KK","year":"2017","unstructured":"Mishra KK, Trivedi A, Sosa S, Patel K, Ghosh K. NAT positivity in seronegative voluntary blood donors from western India. Transfus Apher Sci. 2017, 56:175-8. 10.1016\/j.transci.2016.11.003","journal-title":"Transfus Apher Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2016\/16981.7319","article-title":"Automated triplex (HBV, HCV and HIV) NAT assay systems for blood screening in India","volume":"10","author":"Rajput MK","year":"2016","unstructured":"Rajput MK. Automated triplex (HBV, HCV and HIV) NAT assay systems for blood screening in India. J Clin Diagn Res. 2016, 10:KE01-4. 10.7860\/JCDR\/2016\/16981.7319","journal-title":"J Clin Diagn Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4103\/0973-6247.95056","article-title":"A study on optimization of plasma pool size for viral infectious markers in Indian blood donors using nucleic acid amplification testing","volume":"6","author":"Mathur A","year":"2012","unstructured":"Mathur A, Shah J, Shah R, Shah P, Harimoorthy V, Choudhury N, Tulsiani S. A study on optimization of plasma pool size for viral infectious markers in Indian blood donors using nucleic acid amplification testing. Asian J Transfus Sci. 2012, 6:50-2. 10.4103\/0973-6247.95056","journal-title":"Asian J Transfus Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s12288-022-01564-8","article-title":"Economic evaluation of nucleic acid testing for screening of blood donations for thalassemia patients (ECONAT) in western India","volume":"39","author":"Anne PB","year":"2023","unstructured":"Anne PB, Gupta A, Misra S, et al.. Economic evaluation of nucleic acid testing for screening of blood donations for thalassemia patients (ECONAT) in western India. Indian J Hematol Blood Transfus. 2023, 39:317-24. 10.1007\/s12288-022-01564-8","journal-title":"Indian J Hematol Blood Transfus"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2017\/24131.9337","article-title":"Regulation of molecular diagnostic (NAT) kits for HBV, HCV and HIV in India","volume":"11","author":"Rajput MK","year":"2017","unstructured":"Rajput MK. Regulation of molecular diagnostic (NAT) kits for HBV, HCV and HIV in India. J Clin Diagn Res. 2017, 11:KL01. 10.7860\/JCDR\/2017\/24131.9337","journal-title":"J Clin Diagn Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/407138-added-value-of-nucleic-acid-testing-in-blood-banks-a-15-year-retrospective-study-from-india","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T09:55:18Z","timestamp":1765187718000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/407138-added-value-of-nucleic-acid-testing-in-blood-banks-a-15-year-retrospective-study-from-india"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.98684","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,8]]}}}